Which condition requires caution with aminoglycosides due to possible neuromuscular weakness?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Study for the Foundation Year Pharmacy – Clinical Practice Test. Prepare with detailed questions, step-by-step explanations, and test format insights. Enhance your readiness and confidence!

Multiple Choice

Which condition requires caution with aminoglycosides due to possible neuromuscular weakness?

Explanation:
Aminoglycosides can impair neuromuscular transmission by reducing acetylcholine release at the neuromuscular junction and potentiating neuromuscular blockade. In myasthenia gravis, there are fewer functional acetylcholine receptors at the motor end plate, so the safety margin for muscle contraction is already reduced. Adding an aminoglycoside can tip the balance toward marked weakness and even respiratory failure. This is why caution is needed in this condition. The other listed conditions do not inherently create the same risk for neuromuscular weakness with aminoglycosides.

Aminoglycosides can impair neuromuscular transmission by reducing acetylcholine release at the neuromuscular junction and potentiating neuromuscular blockade. In myasthenia gravis, there are fewer functional acetylcholine receptors at the motor end plate, so the safety margin for muscle contraction is already reduced. Adding an aminoglycoside can tip the balance toward marked weakness and even respiratory failure. This is why caution is needed in this condition. The other listed conditions do not inherently create the same risk for neuromuscular weakness with aminoglycosides.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy